Search Results - "Levitzki, Alexander"

Refine Results
  1. 1

    Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical Performance by LEVITZKI, Alexander

    “…With the manufacture of imatinib, researchers introduced tyrosine kinase inhibitors (TKIs) into the clinical setting in 2000 to treat cancers; approximately…”
    Get full text
    Journal Article
  2. 2

    Tyrphostins and other tyrosine kinase inhibitors by Levitzki, Alexander, Mishani, Eyal

    Published in Annual review of biochemistry (01-01-2006)
    “…The development of tyrosine phosphorylation inhibitors has transformed the approach to cancer therapy and is likely to affect other fields of medicine. In…”
    Get full text
    Journal Article
  3. 3

    Targeting the EGFR and the PKB pathway in cancer by Klein, Shoshana, Levitzki, Alexander

    Published in Current opinion in cell biology (01-04-2009)
    “…The EGFR and PKB pathways are frequently activated in cancer, so are prime targets for cancer therapy. To this end, new inhibitors are being tested. EGFR…”
    Get full text
    Journal Article
  4. 4

    Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment by REUVENI, Hadas, FLASHNER-ABRAMSON, Efrat, STEINER, Lilach, MAKEDONSKI, Kirill, RENDUO SONG, SHIR, Alexei, HERLYN, Meenhard, BAR-ELI, Menashe, LEVITZKI, Alexander

    Published in Cancer research (Chicago, Ill.) (15-07-2013)
    “…Insulin receptor substrates 1 and 2 (IRS1/2) mediate mitogenic and antiapoptotic signaling from insulin-like growth factor 1 receptor (IGF-IR), insulin…”
    Get full text
    Journal Article
  5. 5

    ROS, stress-activated kinases and stress signaling in cancer by Benhar, Moran, Engelberg, David, Levitzki, Alexander

    Published in EMBO reports (01-05-2002)
    “…Anticancer therapy is frequently efficient in early stages of the disease, whereas advanced tumors are usually resistant to the same treatments. The molecular…”
    Get full text
    Journal Article
  6. 6

    Impact of the Anticancer Drug NT157 on Tyrosine Kinase Signaling Networks by Su, Shih-Ping, Flashner-Abramson, Efrat, Klein, Shoshana, Gal, Mor, Lee, Rachel S, Wu, Jianmin, Levitzki, Alexander, Daly, Roger J

    Published in Molecular cancer therapeutics (01-05-2018)
    “…The small-molecule drug NT157 has demonstrated promising efficacy in preclinical models of a number of different cancer types, reflecting activity against both…”
    Get full text
    Journal Article
  7. 7

    Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF by Edinger, Nufar, Lebendiker, Mario, Klein, Shoshana, Zigler, Maya, Langut, Yael, Levitzki, Alexander

    Published in PloS one (06-09-2016)
    “…Selective delivery of drugs to tumor cells can increase potency and reduce toxicity. In this study, we describe a novel recombinant chimeric protein, dsRBEC,…”
    Get full text
    Journal Article
  8. 8

    Information-theoretic analysis of phenotype changes in early stages of carcinogenesis by Remacle, F., Kravchenko-Balasha, Nataly, Levitzki, Alexander, Levine, R. D.

    “…Cancer is a multistep process characterized by altered signal transduction, cell growth, and metabolism. To identify such processes in early carcinogenesis we…”
    Get full text
    Journal Article Web Resource
  9. 9
  10. 10

    Tyrosine Kinase Inhibition: An Approach to Drug Development by Levitzki, Alexander, Gazit, Aviv

    “…Protein tyrosine kinases (PTKs) regulate cell proliferation, cell differentiation, and signaling processes in the cells of the immune system. Uncontrolled…”
    Get full text
    Journal Article
  11. 11

    Cisplatin-induced activation of the EGF receptor by BENHAR, Moran, ENGELBERG, David, LEVITZKI, Alexander

    Published in Oncogene (12-12-2002)
    “…Cisplatin (CDDP) is an efficient DNA-damaging antitumor agent employed for the treatment of various human cancers. CDDP activates nuclear as well as…”
    Get full text
    Journal Article
  12. 12

    On a fundamental structure of gene networks in living cells by Kravchenko-Balasha, Nataly, Levitzki, Alexander, Goldstein, Andrew, Rotter, Varda, Gross, A., Remacle, F., Levine, R. D.

    “…Computers are organized into hardware and software. Using a theoretical approach to identify patterns in gene expression in a variety of species, organs, and…”
    Get full text
    Journal Article Web Resource
  13. 13

    Heterogeneity of gene expression in murine squamous cell carcinoma development-the same tumor by different means by Cohen, Noam, Kravchenko-Balasha, Nataly, Klein, Shoshana, Levitzki, Alexander

    Published in PloS one (18-03-2013)
    “…Transformation is a complex process, involving many changes in the cell. In this work, we investigated the transcriptional changes that arose during the…”
    Get full text
    Journal Article
  14. 14

    EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice by Shir, Alexei, Ogris, Manfred, Wagner, Ernst, Levitzki, Alexander

    Published in PLoS medicine (01-01-2006)
    “…Glioblastoma multiforme (GBM) is the most lethal form of brain cancer. With the available treatments, survival does not exceed 12-14 mo from the time of…”
    Get full text
    Journal Article
  15. 15

    Enhanced ROS Production in Oncogenically Transformed Cells Potentiates c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Activation and Sensitization to Genotoxic Stress by Benhar, Moran, Dalyot, Idan, Engelberg, David, Levitzki, Alexander

    Published in Molecular and Cellular Biology (01-10-2001)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    Development of New Insulin-like Growth Factor-1 Receptor Kinase Inhibitors Using Catechol Mimics by Blum, Galia, Gazit, Aviv, Levitzki, Alexander

    Published in The Journal of biological chemistry (17-10-2003)
    “…Because insulin-like growth factor-1 (IGF-1) and its receptor play a pivotal role in many cancers, it is an attractive target for the design of inhibitors…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Anomalous features of EMT during keratinocyte transformation by Geiger, Tamar, Sabanay, Helena, Kravchenko-Balasha, Nataly, Geiger, Benjamin, Levitzki, Alexander

    Published in PloS one (06-02-2008)
    “…During the evolution of epithelial cancers, cells often lose their characteristic features and acquire a mesenchymal phenotype, in a process known as…”
    Get full text
    Journal Article
  19. 19

    Shift from Apoptotic to Necrotic Cell Death during Human Papillomavirus-induced Transformation of Keratinocytes by Kravchenko-Balasha, Nataly, Mizrachy-Schwartz, Sarit, Klein, Shoshana, Levitzki, Alexander

    Published in The Journal of biological chemistry (24-04-2009)
    “…Oncogenic transformation is a complex, multistep process, which goes through several stages before complete malignant transformation occurs. To identify early…”
    Get full text
    Journal Article
  20. 20

    Substrate Competitive Inhibitors of IGF-1 Receptor Kinase by Blum, Galia, Gazit, Aviv, Levitzki, Alexander

    Published in Biochemistry (Easton) (26-12-2000)
    “…IGF-1 and its receptor play a pivotal role in many cancers, and therefore, IGF-1R is an attractive target for the design of inhibitors. In this communication,…”
    Get full text
    Journal Article